Leonard M. Greenstein, Chief Financial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 5,000 shares at $14.02 ($70K) on 2023-04-20, disclosed to the SEC on 2023-04-21.
Scheduled sale ($70k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TARS | SELL | 2023-03-17 | $71K | — | Filing → |
| TARS | SELL | 2023-02-17 | $76K | — | Filing → |
| TARS | SELL | 2023-01-20 | $73K | — | Filing → |